Here are the key things you need to know about in the NZX markets over the past 24 hours. Changes are as at 3:00 pm and may change when the market closes at 4:45 pm.
WHAT THE NZX 50 INDEX IS DOING
The NZX50 begins the new trading week little changed, easing just -0.1%. Despite the marginal decline, the benchmark remains up +0.9% over five days, +3.8% over the past month and +7.6% over the past year, although it sits slightly lower at -0.2% over six months. The market was firmly negative, with 51 stocks declining compared with 34 gainers.
THE MAIN GAINERS
Leading the gainers was a2 Milk (ATM, #8), which climbed +5% on the day and has now gained +19% over the past week and +24% over the past month, significantly reducing its six-month decline to -20%. Fletcher Building (FBU, #15) advanced +4%, extending gains to +3% over five days and +8% over one month, while remaining up +7% over the past year. Chorus (CNU, #12) added +1%, maintaining gains of +5% over six months and +14% over the past year despite a -4% decline over one month. Ryman Healthcare (RYM, #18) also rose +1%, supported by a +5% monthly gain and a +4% increase over the past year, although the stock remains down -23% over six months.
A2 Milk
Select chart tabs
THE MAIN DECLINERS
Among the decliners, SkyCity Entertainment (SKC, #40) fell -4%, trimming recent momentum but remaining up +5% over both five days and one month, despite declines of -38% over six months and -37% over the past year. Gentrack (GTK, #47) also dropped -4%, adding to a -7% monthly decline and leaving the stock down -56% over six months and -69% over the past year. Kathmandu Brands (KMD, #50) declined -3%, despite remaining up +30% over one month, while continuing to sit -51% lower over both six months and one year. Tourism Holdings (THL, #42) eased -2%, extending its five-day decline to -3%, although the company remains up +17% over one month, +2% over six months and +16% over the past year.
SKYCITY Entertainment
Select chart tabs
SMARTSHARES EFTs
| 1-day | 5-day | 6-month | YTD | 1Y | |
| NZ Top 50 ETF (FNZ) | +0.4% | +1.1% | -3.7% | -4.6% | +4.1% |
| NZ Top 10 ETF (TNZ) | +0.9% | +1.5% | +0.8% | +0.3% | +4.5% |
| S/P NZX50 ETF (NZG) | +0.2% | +1.0% | -1.2% | -1.5% | +4.9% |
| NZ Dividend ETF (DIV) | -0.7% | -0.7% | +0.2% | -1.3% | +12.7% |
KEY ANNOUNCEMENTS
a2 Milk (ATM, #8) has received regulatory approval from China's State Administration for Market Regulation to transition two infant milk formula registrations acquired through the a2 Pokeno facility acquisition to a2-branded products. The approval marks the final regulatory step required under the acquisition and clears the way for the launch of the new products later this year, with no change to previously outlined financial benefits. The company also advised that its Board intends to meet shortly to consider declaring a fully franked and unimputed special dividend of $300 mln, with further details to be announced following any formal declaration.
Oceania Healthcare (OCA, #44) has launched an offer of up to $100 mln of six-year fixed-rate secured bonds, with the ability to accept a further $25 mln in oversubscriptions. The bonds will carry an interest rate based on the swap rate plus a margin expected to be between 1.85% and 1.95%, subject to a minimum interest rate of 5.50% per annum. The offer is open to institutional and retail investors through participating brokers, with pricing expected to be finalised following a bookbuild on the 25th of June and the bonds scheduled to be issued on 1 July 2026 under the ticker code OCA030.
NZX50 Healthcare Sector
Select chart tabs
Click on the chart title to find more about this sector, including its components.
We welcome your comments below. If you are not already registered, please register to comment
Remember we welcome robust, respectful and insightful debate. We don't welcome abusive or defamatory comments and will de-register those repeatedly making such comments. Our current comment policy is here.